A detailed history of Harbour Investments, Inc. transactions in Amgen Inc stock. As of the latest transaction made, Harbour Investments, Inc. holds 5,588 shares of AMGN stock, worth $1.82 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares
5,588
Previous 5,105 9.46%
Holding current value
$1.82 Million
Previous $1.6 Million 12.85%
% of portfolio
0.06%
Previous 0.06%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 04, 2024

BUY
$309.38 - $337.38 $149,430 - $162,954
483 Added 9.46%
5,588 $1.8 Million
Q2 2024

Jul 26, 2024

BUY
$262.75 - $319.31 $137,681 - $167,318
524 Added 11.44%
5,105 $1.6 Million
Q1 2024

Jul 22, 2024

BUY
$268.87 - $324.56 $33,608 - $40,570
125 Added 2.81%
4,581 $1.3 Million
Q4 2023

Feb 16, 2024

BUY
$255.7 - $288.46 $78,755 - $88,845
308 Added 7.43%
4,456 $1.28 Million
Q3 2023

Nov 15, 2023

BUY
$218.65 - $271.46 $5,466 - $6,786
25 Added 0.61%
4,148 $1.11 Million
Q2 2023

Aug 14, 2023

SELL
$214.27 - $253.37 $147,846 - $174,825
-690 Reduced 14.34%
4,123 $915,000
Q1 2023

May 15, 2023

SELL
$225.79 - $275.2 $82,187 - $100,172
-364 Reduced 7.03%
4,813 $1.16 Million
Q4 2022

Feb 15, 2023

SELL
$229.03 - $291.01 $27,025 - $34,339
-118 Reduced 2.23%
5,177 $1.36 Million
Q2 2022

Aug 15, 2022

BUY
$230.71 - $256.74 $7,613 - $8,472
33 Added 0.63%
5,295 $1.29 Million
Q4 2021

Feb 16, 2022

SELL
$198.88 - $227.6 $1.16 Million - $1.33 Million
-5,829 Reduced 52.56%
5,262 $1.18 Million
Q3 2021

Nov 15, 2021

BUY
$212.27 - $248.7 $338,782 - $396,925
1,596 Added 16.81%
11,091 $2.36 Million
Q2 2021

Aug 16, 2021

BUY
$233.58 - $259.14 $172,148 - $190,986
737 Added 8.42%
9,495 $2.31 Million
Q1 2021

Aug 17, 2021

BUY
$221.91 - $258.6 $1.93 Million - $2.25 Million
8,707 Added 17072.55%
8,758 $2.18 Million
Q1 2021

May 12, 2021

BUY
$221.91 - $258.6 $11,317 - $13,188
51 New
51 $13,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $174B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Harbour Investments, Inc. Portfolio

Follow Harbour Investments, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Harbour Investments, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Harbour Investments, Inc. with notifications on news.